Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1976-12-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0300-3396
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
211-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:823633-Arthritis, Rheumatoid,
pubmed-meshheading:823633-Clinical Trials as Topic,
pubmed-meshheading:823633-Female,
pubmed-meshheading:823633-Gold Sodium Thiomalate,
pubmed-meshheading:823633-Humans,
pubmed-meshheading:823633-Male,
pubmed-meshheading:823633-Penicillamine,
pubmed-meshheading:823633-Time Factors
|
pubmed:year |
1976
|
pubmed:articleTitle |
Evidence that D-penicillamine alters the course of rheumatoid arthritis.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|